𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation

✍ Scribed by Lucie Maréchal; Grégory Raux; Cécile Dumanchin; Guillaume Lefebvre; Emmanuelle Deslandre; Carole Girard; Dominique Campion; Dominique Parain; Thierry Frebourg; Didier Hannequin

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
55 KB
Volume
119B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel mutation of the ε-sarcoglycan ge
A novel mutation of the ε-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome
✍ Xue-Ping Chen; Yang-Wei Zhang; Shu-Shan Zhang; Qin Chen; Jean-Marc Burgunder; Sh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

## Abstract In a Chinese myoclonus‐dystonia syndrome (MDS) family presented with a phenotype including a typical MDS, cervical dystonia, and writer's cramp, genetic analyses revealed a novel 662 + 1insG heterozygous mutation in exon 5 in the ε‐sarcoglycan (__SGCE__) gene, leading to a frameshift wi

Myoclonus–dystonia syndrome with severe
Myoclonus–dystonia syndrome with severe depression is caused by an exon-skipping mutation in the ε-sarcoglycan gene
✍ Anjum Misbahuddin; Mark Placzek; Graham Lennox; Jan-Willem Taanman; Thomas T. Wa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract We describe two affected individuals in a family with myoclonus–dystonia syndrome complicated with severe depression. One individual committed suicide. Molecular genetic analysis revealed a heterozygous point mutation in the ε‐sarcoglycan gene, which we show leads to skipping of exon 5.

A gain-of-glycosylation mutation associa
A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse ε-sarcoglycan in the late secretory pathway
✍ Adrian Waite; Maria Cristina De Rosa; Andrea Brancaccio; Derek J. Blake 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Missense mutations in the SGCE gene encoding ε-sarcoglycan account for approximately 15% of SGCE-positive cases of myoclonus-dystonia syndrome (MDS) in humans. In this study, we show that while the majority of MDS-associated missense mutants modeled with a murine ε-sarcoglycan cDNA are substrates fo

Unusually severe expression of craniofac
Unusually severe expression of craniofacial features in Aarskog-Scott syndrome due to a novel truncating mutation of the FGD1 gene
✍ A. Orrico; L. Galli; M.G. Obregon; M.F. de Castro Perez; M. Falciani; V. Sorrent 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 3 views

## Abstract Aarskog‐Scott syndrome (AAS) is a rare, clinically and genetically heterogeneous condition characterized by facial dysmorphic features, short stature, brachydactyly, and genital anomalies. The X‐linked form is caused by mutations of the __FGD1__ gene. Although clinical manifestations an